阿尔茨海默病的遗传表型:机制和潜在的治疗方法
Meina Quan1,2, Shuman Cao1, Qi Wang1,2
1Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053 China.
Phenomics (Cham, Switzerland)
|August 17, 2023
概括
本综述详细介绍了阿尔茨海默病 (AD) 的遗传和分子因素,比较了家族性AD (FAD) 和零星AD (SAD) 现型. 它还探讨了阿尔茨海默病的基因疗法的进展.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 研究已经确定了关键的遗传和分子因素.
- presenilins 和粉样前体蛋白基因的突变与家族性AD (FAD) 有关.
- 像在骨髓状细胞2上表达的触发受体1,林相关受体1和ABC传递器A7这样的基因与FAD发病和进展有关.
研究的目的:
- 审查最近关于阿尔茨海默病的遗传和分子研究.
- 为了比较家族性AD (FAD) 和零星性AD (SAD) 的遗传表型.
- 讨论AD基因治疗的进展和未来的前景.
主要方法:
- 在阿尔茨海默病的遗传和分子研究的文献综述.
- 对FAD和SAD遗传因素的比较分析.
- 审查当前的基因治疗方法对阿尔茨海默病.
主要成果:
- 确定了涉及FAD的关键基因,包括前列林,粉样蛋白前体蛋白,TREM2,SORL1和ABCA7.7.
- 脂蛋白E ε4等位基因是零星AD (SAD) 的主要遗传风险因素,也影响FAD.
- 在FAD和SAD之间的遗传表型中存在显著的重叠和差异.
结论:
- 了解遗传表型对于推进阿尔茨海默病研究至关重要.
- 基因疗法对治疗阿尔茨海默病具有前景,目前正在取得进展.
- 未来的研究应该专注于利用基因洞察力为向的AD疗法.
更多相关视频
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
26.9K
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.0K
相关概念视频
01:22Alzheimer's Disease: Treatment
213
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
213
01:26Alzheimer's Disease: Overview
518
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
518
01:15Parkinson's Disease: Overview
596
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
596
01:28Human Genetics
611
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
611